Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 1
1993 2
1994 1
1998 1
2001 2
2002 1
2003 1
2005 4
2006 6
2007 5
2008 3
2009 3
2010 3
2011 5
2012 3
2013 5
2014 5
2015 6
2016 2
2017 4
2018 5
2019 3
2020 1
2021 3
2022 6
2023 5
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

74 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Bisphosphonate - Induced Nephropathy"
Page 1
Drug-induced nephrotoxicity.
Sales GTM, Foresto RD. Sales GTM, et al. Rev Assoc Med Bras (1992). 2020 Jan 13;66Suppl 1(Suppl 1):s82-s90. doi: 10.1590/1806-9282.66.S1.82. Rev Assoc Med Bras (1992). 2020. PMID: 31939540 Free article. Review.
Acute kidney injury is a very common diagnosis, present in up to 60% of critical patients, and its third main cause is drug toxicity. ...Cases of tubulopathy are very common with amphotericin B, polymyxins, and tenofovir, and cases of glomerulopathies are common with VEGF …
Acute kidney injury is a very common diagnosis, present in up to 60% of critical patients, and its third main cause is drug toxicity. …
Drug-induced glomerular disease: direct cellular injury.
Markowitz GS, Bomback AS, Perazella MA. Markowitz GS, et al. Clin J Am Soc Nephrol. 2015 Jul 7;10(7):1291-9. doi: 10.2215/CJN.00860115. Epub 2015 Apr 10. Clin J Am Soc Nephrol. 2015. PMID: 25862776 Free PMC article. Review.
The potential of medications to cause kidney injury is well known. Although nephrotoxicity is most commonly associated with injury in the tubulointerstitial compartment as either acute tubular necrosis or acute interstitial nephritis, a growing body of literature has also …
The potential of medications to cause kidney injury is well known. Although nephrotoxicity is most commonly associated with injury in …
Low Bone Density and Bisphosphonate Use and the Risk of Kidney Stones.
Prochaska M, Taylor E, Vaidya A, Curhan G. Prochaska M, et al. Clin J Am Soc Nephrol. 2017 Aug 7;12(8):1284-1290. doi: 10.2215/CJN.01420217. Epub 2017 Jun 2. Clin J Am Soc Nephrol. 2017. PMID: 28576907 Free PMC article.
Small studies with short follow-up reported reduced 24-hour urine calcium excretion with bisphosphonate use. We examined history of low bone density and bisphosphonate use and the risk of incident kidney stone as well as the association with 24-hour calcium e …
Small studies with short follow-up reported reduced 24-hour urine calcium excretion with bisphosphonate use. We examined history of l …
Medicine-Induced Acute Kidney Injury Findings from Spontaneous Reporting Systems, Sequence Symmetry Analysis and a Case-Control Study with a Focus on Medicines Used in Primary Care.
Roughead EE, Kerr M, Moffat A, Kassie GM, Pratt N. Roughead EE, et al. Drug Saf. 2022 Nov;45(11):1413-1421. doi: 10.1007/s40264-022-01238-4. Epub 2022 Sep 21. Drug Saf. 2022. PMID: 36127547 Free PMC article.
INTRODUCTION: Primary care provides an opportunity to prevent community acquired, medicine or drug-induced acute kidney injury. One of the barriers to proactive prevention of medicine-induced kidney injury in primary care is the lack of a list of nephr …
INTRODUCTION: Primary care provides an opportunity to prevent community acquired, medicine or drug-induced acute kidney injury …
Glomerular diseases seen with cancer and chemotherapy: a narrative review.
Jhaveri KD, Shah HH, Calderon K, Campenot ES, Radhakrishnan J. Jhaveri KD, et al. Kidney Int. 2013 Jul;84(1):34-44. doi: 10.1038/ki.2012.484. Epub 2013 Jan 30. Kidney Int. 2013. PMID: 23364518 Free article. Review.
Glomerular lesions have been recognized in a number of malignant diseases. Membranous nephropathy is the most common glomerular pathology associated with solid tumors. ...Chemotherapy agents such as interferon, anti-vascular endothelial growth factor agents, tyrosin …
Glomerular lesions have been recognized in a number of malignant diseases. Membranous nephropathy is the most common glomerula …
Targeted microbubbles: a novel application for the treatment of kidney stones.
Ramaswamy K, Marx V, Laser D, Kenny T, Chi T, Bailey M, Sorensen MD, Grubbs RH, Stoller ML. Ramaswamy K, et al. BJU Int. 2015 Jul;116(1):9-16. doi: 10.1111/bju.12996. Epub 2015 Mar 17. BJU Int. 2015. PMID: 25402588 Free PMC article. Review.
The shockwaves induced the formation of cavitation bubbles, whose collapse released energy at the stone, and the energy fragmented the kidney stones into pieces small enough to be passed spontaneously. ...Two important observations have been established: (i) bisp …
The shockwaves induced the formation of cavitation bubbles, whose collapse released energy at the stone, and the energy fragmented th …
Bisphophonates in CKD patients with low bone mineral density.
Liu WC, Yen JF, Lang CL, Yan MT, Lu KC. Liu WC, et al. ScientificWorldJournal. 2013 Dec 31;2013:837573. doi: 10.1155/2013/837573. eCollection 2013. ScientificWorldJournal. 2013. PMID: 24501586 Free PMC article. Review.
Patients with chronic kidney disease-mineral and bone disorder (CKD-MBD) have a high risk of bone fracture because of low bone mineral density and poor bone quality. ...Therefore, bone biopsy in advanced CKD is an important consideration before prescribing bisphosphonat …
Patients with chronic kidney disease-mineral and bone disorder (CKD-MBD) have a high risk of bone fracture because of low bone minera …
Bisphosphonate use and risk of renal cell carcinoma: A population-based case-control study.
Chung BI, Hellfritzsch M, Ulrichsen SP, Sørensen HT, Ehrenstein V. Chung BI, et al. Basic Clin Pharmacol Toxicol. 2019 May;124(5):642-646. doi: 10.1111/bcpt.13180. Epub 2019 Jan 4. Basic Clin Pharmacol Toxicol. 2019. PMID: 30472809 Free article.
The purpose of this study was to evaluate the association between the use of bisphosphonates and the risk of developing renal cell carcinoma (RCC). ...There were 2748 RCC cases and 27 480 controls. The adjusted ORs for ever vs never bisphosphonate use were 1.07 (95% …
The purpose of this study was to evaluate the association between the use of bisphosphonates and the risk of developing renal cell ca …
Vascular calcification and arterial stiffness in chronic kidney disease: implications and management.
Toussaint ND, Kerr PG. Toussaint ND, et al. Nephrology (Carlton). 2007 Oct;12(5):500-9. doi: 10.1111/j.1440-1797.2007.00823.x. Nephrology (Carlton). 2007. PMID: 17803475 Review.
Cardiovascular (CV) disease is the commonest cause of mortality in patients with chronic kidney disease (CKD). Vascular calcification (VC), induced by calcium and phosphate excess and uraemia, is a major risk factor and is independently associated with CV events and …
Cardiovascular (CV) disease is the commonest cause of mortality in patients with chronic kidney disease (CKD). Vascular calcification …
Bisphosphonate treatment of tumor-induced hypercalcemia in a toddler: case report and review of related literature.
Mastrandrea LD, Albini CH. Mastrandrea LD, et al. Endocr Pract. 2006 Nov-Dec;12(6):670-5. doi: 10.4158/EP.12.6.670. Endocr Pract. 2006. PMID: 17229665 Review.
Because of refractory hypercalcemia, intravenously administered bisphosphonate was used. Within 12 hours after bisphosphonate infusion, the serum calcium level declined from 14.9 mg/dL to 10.9 mg/dL. ...Hypercalcemia in the pediatric population can be treated effect …
Because of refractory hypercalcemia, intravenously administered bisphosphonate was used. Within 12 hours after bisphosphonate …
74 results